OOIR: Observatory of International Research

Papers

(The TQCC of Clinics in Laboratory Medicine is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Blood Banking and Transfusion Medicine Challenges During the COVID-19 Pandemic	77
Panels and Syndromic Testing in Clinical Microbiology	46
Modern Blood Culture	28
Hemolytic Disease of the Fetus and Newborn	21
Update on Lymphoblastic Leukemia/Lymphoma	18
Transfusion in Neonatal Patients	17
Glycan Imaging Mass Spectrometry	17
Antibody Dynamics and Durability in Coronavirus Disease-19	16
Matrix-Assisted Laser Desorption Ionization Time-of-Flight for Fungal Identification	16
Mass Cytometry, Imaging Mass Cytometry, and Multiplexed Ion Beam Imaging Use in a Clinical Setting	15
Breath-Based Diagnosis of Infectious Diseases	15
Platelet Transfusion	14
Massive Transfusion in Pediatric Patients	13
Clinical Mass Spectrometry Approaches to Myeloma and Amyloidosis	13
Transfusion Reactions and Adverse Events	13
Clinical Pathogen Genomics	13
Bringing Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging to the Clinics	12
Measuring the Serologic Response to Severe Acute Respiratory Syndrome Coronavirus 2	12
Update on Susceptibility Testing	11
Point-of-Care Testing in Microbiology	11
Performance Characteristics of High-Throughput Serologic Assays for Severe Acute Respiratory Syndrome Coronavirus 2 with Food and Drug Administration Emergency Use Authorization	10
Implementation of Mass Spectrometry Imaging in Pathology	10
Antigen Loss after Targeted Immunotherapy in Hematological Malignancies	9
Rapid Antigen Assays for SARS-CoV-2	9
Transfusion and Cellular Therapy in Pediatric Sickle Cell Disease	9

Breaking Through the Barrier	9
Practical Challenges of Point-of-Care Testing	8
Vaccine-Induced Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and the Path to Accelerating Development (Determining a Correlate of Protection)	7
Performance Evaluation of Lateral Flow Assays for Coronavirus Disease-19 Serology	7
The Successes and Challenges of SARS-CoV-2 Molecular Testing in the United States	7
Inherited Bone Marrow Failure Syndromes	7
Transfusion in Pediatric Patients	6
Whole Blood Transfusion	6
Artificial Intelligence Applications in Clinical Chemistry	6
Molecular Diagnostic Testing for Hematopoietic Neoplasms	6
An Overview of SARS-CoV-2 Molecular Diagnostics in Europe	6
Role of Minimal Residual Disease Testing in Acute Myeloid Leukemia	6
Clinical Cytometry for Platelets and Platelet Disorders	5
Next-Generation Sequencing Approaches to Predicting Antimicrobial Susceptibility Testing Results	5
Food Safety Genomics and Connections to One Health and the Clinical Microbiology Laboratory	5
Update on Acute Leukemias of Ambiguous Lineage	5
Reactive Lymphadenopathies	5
Red Blood Cell Transfusion	5
Clinical Diagnostic Point-of-Care Molecular Assays for SARS-CoV-2	5
Strategies for Scaling up SARS-CoV-2 Molecular Testing Capacity	5
Opportunities and Challenges with Artificial Intelligence in Genomics	5
Pediatric Myelodysplastic Syndromes	5
Update on Biosafety and Emerging Infections for the Clinical Microbiology Laboratory	4
Blood Group Genotyping	4
Granulocyte Transfusion	4
Hematopathologic Correlates of CAR T-Cell Therapy	4
Copy Number Analysis in Cancer Diagnostic Testing	4
Pediatric Hemovigilance and Adverse Transfusion Reactions	4
Digital Health	4
Molecular Biomarkers of Response to Cancer Immunotherapy	4
Diagnostic Stewardship for Next-Generation Sequencing Assays in Clinical Microbiology	4
Transfusion Medicine Informatics	4
Update in Infectious Disease Diagnosis in Anatomic Pathology	4
Cycle Threshold Values from Severe Acute Respiratory Syndrome Coronavirus-2 Reverse Transcription-Polymerase Chain Reaction Assays	4
Using Artificial Intelligence to Better Predict and Develop Biomarkers	4
The Hematological Differential Diagnosis of Mediastinal Masses	4
Molecular Genetics of Pediatric Acute Myeloid Leukemia	4
Update on Ovarian Sex Cord–Stromal Tumors	4
Infant Acute Leukemia	4
Germline Predisposition to Myeloid Neoplasms	3
Novel Assays/Applications for Patients Suspected of Mycobacterial Diseases	3
Evolving Approach to Clinical Cytometry for Immunodeficiencies and Other Immune Disorders	3
Clinical Artificial Intelligence	3
A New Landscape of Testing and Therapeutics in Metastatic Breast Cancer	3
Approaches to Deployment of Molecular Testing for SARS-CoV-2 in Resource-Limited Settings	3
Building Evidence for Clinical Use of Pharmacogenomics and Reimbursement for Testing	3
Advances in Clinical Mass Cytometry	3
Update in Transfusion Medicine Education	3
Artificial Intelligence for Clinical Flow Cytometry	3
Analytical Principles of Cancer Next Generation Sequencing	3